CLINICAL_TRIALS
research
· 2026-03-03
Clinical Trial Update: First in Human Study of TUB-030 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Summary
First-in-human study of TUB-030 is underway in patients with advanced solid tumors, including head and neck squamous cell carcinoma, small cell lung cancer, non…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tubulis GmbH | Conditions: Advanced Solid Tumors, HNSCC | Phase 1, Phase 2 | Status: RECRUITING